Supplementing lactating women with lutein is an effective way of raising the lutein status of the breast-feeding infant, says a new study from Abbott Nutrition with potential implications for eye and cognitive health of children.

Daily supplements of lutein (Floraglo Lutein from Kemin Industries) at doses of 6 or 12 milligrams per day for new mothers for six weeks resulted in significant increases in the lutein concentrations in the breast milk, maternal plasma, and the infant’s plasma in a dose-dependent manner, according to results published in the Journal of Nutrition.

“Whether or not lutein can affect cognitive development early in life is not yet known,” wrotethe researchers, led by Christina Sherry, PhD, RD. “Nonetheless, breast milk or infant formula is the sole source of nutrition during this critical period of development. Given the relation between intake of lutein by the breastfeeding mother, infant plasma concentrations, and the importance of lutein as an antioxidant and in eye health, it is prudent that lactating women consume adequate lutein from the diet or supplements to ensure adequate concentrations in breast milk for infant growth and development.”

“We have found that lutein is the dominant carotenoid (about 60% of the total) in pediatric (0-11 months) brain tissue [Vishwanathan et al, Journal of Pediatric Gastroenterology & Nutrition]. This is not likely due to dietary intakes, as NHANES data finds that lutein is about 12% of total intake,” she said. “Therefore, just as in the macula, where there is preferential uptake of lutein over the hundreds of other carotenoids, there appears to be preferential uptake for lutein into pediatric brain tissue as well.”

Study details

Dr Sherry and her co-workers recruited 89 lactating women who had given birth four to six weeks earlier and randomly assigned them to one of three lutein dose groups: 0 mg/d of lutein (placebo), or 6 or 12 milligrams per day of the carotenoid.

After six weeks of intervention, the results showed that total lutein + zeaxanthin concentrations increased in the low and high dose groups by 140% and 250%, respectively, in breast milk, compared with placebo. Increases of 170% and 250% were observed in maternal plasma for the low- and high-dose groups, respectively, while total lutein + zeaxanthin concentrations in the infant plasma increased by 180% and 330% in the low- and high-dose groups, respectively.

Levels of other carotenoids in lactating women or their infants were unaffected by lutein supplementation, said the researchers.

“This is the first longitudinal study, to our knowledge, to report the breast milk and plasma concentrations of carotenoids 2-3 months postpartum and to investigate the effect of lutein supplementation during this period,” wrote Dr Sherry and her co-workers.

Supplementing lactating women with lutein is an effective way of raising the lutein status of the breast-feeding infant, says a new study from Abbott Nutrition with potential implications for eye and cognitive health of children.

Related products

On-Demand Supplier Webinar

12-Nov-2014 -
What’s hot in dietary supplements?
What’s the next break-out ingredient?
Can sports nutrition continue to flex its muscle?
What’s happening with online retailers?
Are there any regulatory hotspots to watch for?
Where’s the potential in foreign markets?
What next for GMOs and ‘natural’?
What’s on the horizon...

Technical / white paper

01-Mar-2015 - Astaxanthin is absorbed into all cells of the body, and can cross the the blood-brain barrier to protect the nervous system. Astaxanthin's singlet oxygen quenching capacity is 6000 times stronger than Vitamin C and 550 times stronger than Vitamin E.

Technical / white paper

17-Feb-2015 - SOD B® - A concentrate of youthContrary to common perception, our body produces its own antioxidants called primary antioxidants (SOD, CAT, GPx) acting at the source of the oxidative stress reaction. As we age, we produce less primary antioxidants, reducing...

Case study

05-Feb-2015 - One of nature’s most powerful antioxidants supporting joint, cardio, brain, eye health and overall graceful aging, Zanthin® offers one of the most powerful lipophilic antioxidants yet discovered.Now you can target the most important issues for baby boomers with an ingredient...

Application note

02-Feb-2015 - Marinova is an Australian biotechnology company dedicated to the research, development and manufacture of fucoidan extracts - complex sulfated polysaccharides derived from brown seaweed. Fucoidans are safe, natural compounds with wide ranging bioactivities that make them particularly beneficial in dietary...

Clinical study

01-Feb-2015 - Cyactiv™, a brilliant “blue antioxidant” provides a new path to a healthy inflammation response allowing for an active lifestyle and overall wellness. Cyactiv is a natural, GRAS-designated microalgae extract, which is clinically proven to reduce physical discomfort in joints and...

Data sheet

19-Jan-2015 - Oximacro® is a cranberry powder and liquid extract with the highest content of Proanthocyanidins (PACs, 36%) on the market.It is produced by Biosfered S.r.l. – an Academic Spin-Off of the University of Turin, Italy – using its proprietary technology, and its...

Technical / white paper

18-Feb-2015 - Gone are the days when the Brand Owner or Own Label Distributor could abdicate the responsibility for the quality of their products to the Contract Manufacturing Organization. This is exactly why Gemini Pharmaceuticals
developed a Quality Partnership Program. With over...